NeoGenomics Inc. Announces General Counsel Transition

What Happened

• NeoGenomics, Inc. filed an 8-K on August 11, 2026 announcing that Alicia Olivo, EVP, General Counsel & Business Development, will cease serving as General Counsel effective September 21, 2026.
• Ms. Olivo will remain an employee through October 2, 2026 for transitional purposes.

Key Details

• Filing date: August 11, 2026.
• Effective date as General Counsel: September 21, 2026.
• Final employment/transition end date: October 2, 2026.
• Separation payments and benefits: Ms. Olivo will be eligible for payments consistent with Section 5(b) of her employment agreement (form incorporated by reference in NeoGenomics’ 2025 Form 10-K filed Feb 17, 2026); the 8-K does not disclose dollar amounts.

Why It Matters

• This 8-K reports a leadership change in NeoGenomics’ legal and business development function with a defined transition period. The company indicates separation benefits will follow the existing employment agreement, but no monetary details were provided.
• For investors, track future filings or company announcements for information on the successor General Counsel, any material financial terms disclosed, or impacts on corporate governance or regulatory matters; material effects would be reported in subsequent SEC filings.